Article | January 1, 2022

Strategy For Host Cell Protein Control

Source: Cytiva
iStock-1287080337-lab-microscope-scientist-research.jpg

Advances in the life sciences industry have led to the creation of life-changing therapeutics that transform human health. A critical aspect of therapeutic development and manufacture is host cell protein (HCP) detection, quantitation, and removal from drug substances, to ensure efficacy and prevent immunogenicity. These processes require robust technologies that deliver integrated performance, backed by trusted expertise. 

This article reviews a range of solutions to support scientists and developers in creating an effective strategy for HCP control.

VIEW THE ARTICLE!
Signing up provides unlimited access to:
Signing up provides unlimited access to:
  • Trend and Leadership Articles
  • Case Studies
  • Extensive Product Database
  • Premium Content
HELLO. PLEASE LOG IN. X

Not yet a member of BioProcess Online? Register today.

ACCOUNT SIGN UP X
Please fill in your account details
Login Information
ACCOUNT SIGN UP

Subscriptions

Sign up for the newsletter that brings you the industry's latest news, technologies, trends and products.

You might also want to: